CHAMPS Luggage marks its 35th anniversary, celebrating decades of craftsmanship and reliability. The Canadian brand continues to define premium travel essentials, expanding its heritage collections and modernizing designs while maintaining a strong presence across North… Read More »CHAMPS Luggage Celebrates 35 Years of Crafting Trusted Travel Companions
London, England, United Kingdom, November 7, 2025 — Imprint.live, the purpose-driven platform for young creatives and socially conscious audiences, today announced the launch of its mobile app for IOS downloads from the Apple App Store,… Read More »Imprint.live Launches Mobile App, Empowering Users to Turn Online Engagement Into Real-World Change
If you’re looking for the best pour-over kettles with variable temperature control, I’ve found some top options that combine precise brewing, sleek design, and quick heating. Many models feature gooseneck spouts for controlled pouring, digital… Read More »15 Best Pour-Over Kettles With Variable Temperature for Perfect Coffee Brewing
BEIJING, Nov. 7, 2025 /PRNewswire/ — A news report from China.org.cn on the 8th CIIE and China’s high-quality development:  Anchoring the 15th Five-Year Plan: China’s High-quality Development is Strengthening Foreign Investors’ Confidence Recently, China released… Read More »Anchoring the 15th Five-Year Plan: China’s High-quality Development is Strengthening Foreign Investors’ Confidence
LEWES, Del., Nov. 7, 2025 /PRNewswire/ — HiBy has officially launched its new flagship portable HiFi player, RS8 II, on October 30, 2025. The RS8 II integrates HiBy’s advanced technologies in portable audio with… Read More »HiBy RS8 II Ultra-Flagship Portable HiFi Player Released
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI for… Read More »Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025